MeSH tree: C04.588.894
Researchers at The University of Texas MD Anderson Cancer Center have developed an artificial intelligence (AI) model that can identify lung cancer patients at increased risk of developing a serious immunotherapy-related ...
Sep 25, 2026
0
7
Chemotherapy faces a fundamental problem: The same drugs powerful enough to kill cancer cells can also damage healthy tissue. UC Irvine researchers are trying to change that equation by putting a safety lock on a highly potent ...
Sep 24, 2026
0
16
Human breath could help identify cancerous lung nodules and reduce the need for invasive testing. New Griffith University research analyzed exhaled breath to help doctors distinguish between cancerous and noncancerous lung ...
Sep 24, 2026
0
7
There are substantial health hazards to working with engineered stone countertops, as an article on silicosis, a disease caused by inhaling silica crystals, illustrates in a study appearing in the Canadian Medical Association ...
Sep 21, 2026
0
8
A rare inherited mutation in the Epidermal Growth Factor Receptor (EGFR) gene is associated with a 25-fold increased risk of lung cancer, according to a study by investigators at Dana-Farber Cancer Institute and 23andMe Research ...
Sep 17, 2026
0
43
Blood test trends alongside unexplained weight loss can improve triage for cancer testing, according to a study by Brian Nicholson and colleagues from the University of Oxford, UK, published Sept. 17 in the journal PLOS Medicine.
Sep 17, 2026
0
19
As climate change drives more frequent and intense wildfires, researchers at the Icahn School of Medicine at Mount Sinai have published two large-scale studies showing that wildfire smoke may pose greater health risks than ...
Sep 17, 2026
0
14
In the SWOG S1827 MAVERICK Phase III randomized trial, patients with small-cell lung cancer (SCLC) who underwent regular brain MRI surveillance without prophylactic cranial irradiation (PCI) had significantly better cognitive ...
Sep 15, 2026
0
7
Mobile low-dose computed tomography (LDCT) screening can reach high-risk and socially vulnerable populations in resource-limited settings, according to initial results from the Third Brazilian Early Lung Cancer Trial (BRELT3) ...
Sep 15, 2026
0
2
Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides durable clinical benefit ...
Sep 15, 2026
0
7
